肾内科指南

订阅

MedSci主页 / 所有栏目 / 肾内科指南

血液灌流在维持性血液透析患者中的临床应用上海专家共识

2021-09-30 上海市医学会 上海医学

血液透析

维持性血液透析（ＭＨＤ）患者体内蛋白结合毒素和中大分子毒素的蓄积是导致其发生远期并发症的原因之一。

中文标题：

血液灌流在维持性血液透析患者中的临床应用上海专家共识

发布机构：

上海市医学会

发布日期：

2021-09-30

简要介绍：

维持性血液透析（ＭＨＤ）患者体内蛋白结合毒素和中大分子毒素的蓄积是导致其发生远期并发症的原因之一。血液灌流能清除这些尿毒症毒素，减少ＭＨＤ患者远期并发症发生。上海市医学会肾脏病专科分会参考国内外文献，结合临床诊疗实践经验，从适宜患者、治疗频次、治疗方式、不良反应及注意事项４方面制订血液灌流在ＭＨＤ患者中的临床应用共识，旨在为ＭＨＤ患者血液灌流的合理、规范化治疗提供指导性意见。

相关资料下载：
[AttachmentFileName(sort=1, fileName=血液灌流在维持性血液透析患者中的临床应用上海专家共识.pdf)] GetToolGuiderByIdResponse(projectId=1, id=d54461c0022ae7da, title=血液灌流在维持性血液透析患者中的临床应用上海专家共识, enTitle=, guiderFrom=上海医学, authorId=0, author=, summary=维持性血液透析（ＭＨＤ）患者体内蛋白结合毒素和中大分子毒素的蓄积是导致其发生远期并发症的原因之一。, cover=https://img.medsci.cn/2021111/1635732491183_5579292.jpg, journalId=0, articlesId=null, associationId=1131, associationName=上海市医学会, associationIntro=null, copyright=0, guiderPublishedTime=Thu Sep 30 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">维持性血液透析（ＭＨＤ）患者体内蛋白结合毒素和中大分子毒素的蓄积是导致其发生远期并发症的原因之一。血液灌流能清除这些尿毒症毒素，减少ＭＨＤ患者远期并发症发生。上海市医学会肾脏病专科</span><span style="color: #373737;">分会参考国内外文献，结合临床诊疗实践经验，从适宜患者、治疗频次、治疗方式、不良反应及注意事项４方面制订血液灌流在ＭＨＤ患者中的临床应用共识，旨在为ＭＨＤ患者血液灌流的合理、规范化治疗提供指导性意见。</span></p>, tagList=[TagDto(tagId=2080, tagName=血液透析)], categoryList=[CategoryDto(categoryId=14, categoryName=肾内科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=2080, guiderKeyword=血液透析, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2682, appHits=156, showAppHits=0, pcHits=734, showPcHits=2526, likes=1, shares=26, comments=4, approvalStatus=1, publishedTime=Mon Nov 01 10:26:46 CST 2021, publishedTimeString=2021-09-30, pcVisible=1, appVisible=1, editorId=5579292, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=FUNNYMAN, createdTime=Mon Nov 01 10:12:16 CST 2021, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Sat Jan 06 15:57:34 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=血液灌流在维持性血液透析患者中的临床应用上海专家共识.pdf)])
血液灌流在维持性血液透析患者中的临床应用上海专家共识.pdf
下载请点击：
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1206956, encodeId=0b70120695653, content=正需要, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=016c5557290, createdName=水水在学习, createdTime=Tue Mar 29 16:45:04 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203636, encodeId=f23f120363637, content=好好学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e305452776, createdName=ms2000000991580947, createdTime=Thu Mar 17 22:53:55 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077772, encodeId=a33110e77727c, content=想学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09085473585, createdName=ms4000002104268667, createdTime=Tue Dec 07 15:38:11 CST 2021, time=2021-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068629, encodeId=652a1068629dc, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b8ca2458487, createdName=12410831m21(暂无昵称), createdTime=Tue Nov 09 16:20:48 CST 2021, time=2021-11-09, status=1, ipAttribution=)]
    2022-03-29 水水在学习

    正需要

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1206956, encodeId=0b70120695653, content=正需要, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=016c5557290, createdName=水水在学习, createdTime=Tue Mar 29 16:45:04 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203636, encodeId=f23f120363637, content=好好学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e305452776, createdName=ms2000000991580947, createdTime=Thu Mar 17 22:53:55 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077772, encodeId=a33110e77727c, content=想学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09085473585, createdName=ms4000002104268667, createdTime=Tue Dec 07 15:38:11 CST 2021, time=2021-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068629, encodeId=652a1068629dc, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b8ca2458487, createdName=12410831m21(暂无昵称), createdTime=Tue Nov 09 16:20:48 CST 2021, time=2021-11-09, status=1, ipAttribution=)]
    2022-03-17 ms2000000991580947

    好好学习一下

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1206956, encodeId=0b70120695653, content=正需要, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=016c5557290, createdName=水水在学习, createdTime=Tue Mar 29 16:45:04 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203636, encodeId=f23f120363637, content=好好学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e305452776, createdName=ms2000000991580947, createdTime=Thu Mar 17 22:53:55 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077772, encodeId=a33110e77727c, content=想学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09085473585, createdName=ms4000002104268667, createdTime=Tue Dec 07 15:38:11 CST 2021, time=2021-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068629, encodeId=652a1068629dc, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b8ca2458487, createdName=12410831m21(暂无昵称), createdTime=Tue Nov 09 16:20:48 CST 2021, time=2021-11-09, status=1, ipAttribution=)]
    2021-12-07 ms4000002104268667

    想学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1206956, encodeId=0b70120695653, content=正需要, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=016c5557290, createdName=水水在学习, createdTime=Tue Mar 29 16:45:04 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203636, encodeId=f23f120363637, content=好好学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e305452776, createdName=ms2000000991580947, createdTime=Thu Mar 17 22:53:55 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077772, encodeId=a33110e77727c, content=想学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09085473585, createdName=ms4000002104268667, createdTime=Tue Dec 07 15:38:11 CST 2021, time=2021-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068629, encodeId=652a1068629dc, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b8ca2458487, createdName=12410831m21(暂无昵称), createdTime=Tue Nov 09 16:20:48 CST 2021, time=2021-11-09, status=1, ipAttribution=)]
    2021-11-09 12410831m21(暂无昵称)

    学习了

    0

相关指南

2019 ERBP临床实践指南：成人血液透析患者动静脉瘘和移植物围术期和术后护理

欧洲肾脏最佳临床实践(ERBP,European Renal Best Practice) · 2019-06-01

2019 AIOM/SIN共识意见：慢性肾病或血液透析的癌症患者的靶向治疗管理

意大利肿瘤医学协会(AIOM,Italian Association of Medical Oncology) · 2019-05-31

2019 香港肾脏服务临床实践指南：血液透析

香港医学相关专家组（统称） · 2019-03-02

2019 ESPN共识：需要维持性血液透析儿童患者的血管通路

欧洲儿科肾脏病学会(ESPU,European Society for Paediatric Nephrology) · 2019-03-11

2018 KHA-CARI指南：血液透析中心感染控制建议

澳大利亚肾病指南委员会(CARI,Caring for Australasians with Renal Impairment) · 2018-10-16

2017年ISRNM《血液透析治疗期间饮食》专家共识解读

暂未更新 · 2018-07-20

拓展阅读

血液透析室建设与管理指南

暂未更新 · 2016-04-20

2012 JSDT指南：糖尿病患者血液透析

暂未更新 · 2012-03-19

2017 NICE诊断指南：多频生物电阻抗装置指导慢性肾病患者进行血液透析时的液体管理（DG.29）

暂未更新 · 2017-06-21

2017 KSN临床实践指南：中东呼吸综合征血液透析治疗

韩国肾脏病学会(KSN,Korean Society of Nephrology) · 2017-06-01

2017 ISRNM共识声明：血液透析治疗期间饮食

国际肾营养和代谢学会(ISRNM,International Society of Renal Nutrition and Metabolism) · 2017-12-20

2017年ISRNM《血液透析治疗期间饮食》专家共识解读

暂未更新 · 2018-07-20